Vertex Pharmaceuticals
VRTX
VRTX
1,202 hedge funds and large institutions have $74.9B invested in Vertex Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 109 funds opening new positions, 458 increasing their positions, 464 reducing their positions, and 95 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
1% less repeat investments, than reductions
Existing positions increased: 458 | Existing positions reduced: 464
1% less funds holding
Funds holding: 1,218 → 1,202 (-16)
11% less funds holding in top 10
Funds holding in top 10: 27 → 24 (-3)
Holders
1,202
Holding in Top 10
24
Calls
$447M
Puts
$355M
Top Buyers
| 1 | +$1.06B | |
| 2 | +$596M | |
| 3 | +$274M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$255M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$217M |
Top Sellers
| 1 | -$501M | |
| 2 | -$267M | |
| 3 | -$219M | |
| 4 |
Jennison Associates
New York
|
-$169M |
| 5 |
Man Group
London,
United Kingdom
|
-$166M |